The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Adams, Mark N ^a,b   Christensen, Melinda E ^a   He, Yaowu ^a   Waterhouse, Nigel J ^a   Hooper, John D ^a  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMOPALMITIC ACID; BETA ARRESTIN; CALCIUM ION; CYSTEINE; PROTEINASE ACTIVATED RECEPTOR 2; RAB11 PROTEIN; RAB11A PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL SURFACE; CELL TRACKING; CHO CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA SEQUENCE; ENDOCYTOSIS; FLOW CYTOMETRY; GOLGI COMPLEX; HAMSTER; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PALMITOYLATION; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ARRESTINS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; CYSTEINE; ENDOCYTOSIS; GOLGI APPARATUS; HUMANS; LIPOYLATION; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; PALMITATES; PROTEIN TRANSPORT; PROTEOLYSIS; RAB GTP-BINDING PROTEINS; RECEPTOR, PAR-2; SECRETORY PATHWAY; SIGNAL TRANSDUCTION;

EID: 82255161850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028018     Document Type: Article

References (78)

1. Adams MN, Ramachandran R, Yau MK, Suen JY, Fairlie DP, et al. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 130: 248-282.
2. Ramachandran R, Hollenberg MD, (2008) Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153 (Suppl 1): S263-282.
3. Camerer E, Barker A, Duong DN, Ganesan R, Kataoka H, et al. Local protease signaling contributes to neural tube closure in the mouse embryo. Dev Cell 18: 25-38.
4. Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, et al. (2003) Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 111: 35-41.
5. Vergnolle N, Hollenberg MD, Sharkey KA, Wallace JL, (1999) Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 127: 1083-1090.
6. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, et al. (2001) Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 7: 821-826.
7. Vergnolle N, (2005) Clinical relevance of proteinase activated receptors (pars) in the gut. Gut 54: 867-874.
8. Versteeg HH, Schaffner F, Kerver M, Ellies LG, Andrade-Gordon P, et al. (2008) Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 68: 7219-7227.
9. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J, (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci U S A 91: 9208-9212.
10. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, et al. (1997) Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272: 4043-4049.
11. Camerer E, Huang W, Coughlin SR, (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 97: 5255-5260.
12. Ramsay AJ, Dong Y, Hunt ML, Linn M, Samaratunga H, et al. (2008) Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression. J Biol Chem 283: 12293-12304.
13. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, et al. (2006) Proteinase-activated receptors, targets for kallikrein signaling. J Biol Chem 281: 32095-32112.
14. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, et al. (2000) beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-1281.
15. Ricks TK, Trejo J, (2009) Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization. J Biol Chem 284: 34444-34457.
16. Jacob C, Cottrell GS, Gehringer D, Schmidlin F, Grady EF, et al. (2005) c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J Biol Chem 280: 16076-16087.
17. Bohm SK, Khitin LM, Grady EF, Aponte G, Payan DG, et al. (1996) Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J Biol Chem 271: 22003-22016.
18. Hasdemir B, Murphy JE, Cottrell GS, Bunnett NW, (2009) Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2. J Biol Chem 284: 28453-28466.
19. Roosterman D, Schmidlin F, Bunnett NW, (2003) Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2. Am J Physiol Cell Physiol 284: C1319-1329.
20. Grimsey N, Soto AG, Trejo J, (2011) Regulation of protease-activated receptor signaling by post-translational modifications. IUBMB Life 63: 403-411.
21. Botham A, Guo X, Xiao YP, Morice AH, Compton SJ, et al. (2011) Palmitoylation of human proteinase-activated receptor-2 differentially regulates receptor-triggered ERK1/2 activation, calcium signalling and endocytosis. Biochem J 438: 359-367.
22. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC, (1992) Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11: 1-20.
23. Magee AI, Courtneidge SA, (1985) Two classes of fatty acid acylated proteins exist in eukaryotic cells. EMBO J 4: 1137-1144.
24. Escriba PV, Wedegaertner PB, Goni FM, Vogler O, (2007) Lipid-protein interactions in GPCR-associated signaling. Biochim Biophys Acta 1768: 836-852.
25. Qanbar R, Bouvier M, (2003) Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol Ther 97: 1-33.
26. Delos Santos NM, Gardner LA, White SW, Bahouth SW, (2006) Characterization of the residues in helix 8 of the human beta1-adrenergic receptor that are involved in coupling the receptor to G proteins. J Biol Chem 281: 12896-12907.
27. Anavi-Goffer S, Fleischer D, Hurst DP, Lynch DL, Barnett-Norris J, et al. (2007) Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms. J Biol Chem 282: 25100-25113.
28. Swift S, Leger AJ, Talavera J, Zhang L, Bohm A, et al. (2006) Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism. J Biol Chem 281: 4109-4116.
29. Shaner NC, Steinbach PA, Tsien RY, (2005) A guide to choosing fluorescent proteins. Nat Methods 2: 905-909.
30. Rzomp KA, Scholtes LD, Briggs BJ, Whittaker GR, Scidmore MA, (2003) Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect Immun 71: 5855-5870.
31. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, et al. (2003) Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci U S A 100: 10782-10787.
32. Compton SJ, Sandhu S, Wijesuriya SJ, Hollenberg MD, (2002) Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. Biochem J 368: 495-505.
33. Drisdel RC, Green WN, (2004) Labeling and quantifying sites of protein palmitoylation. Biotechniques 36: 276-285.
34. Wan J, Roth AF, Bailey AO, Davis NG, (2007) Palmitoylated proteins: purification and identification. Nat Protoc 2: 1573-1584.
35. Martin BR, Cravatt BF, (2009) Large-scale profiling of protein palmitoylation in mammalian cells. Nat Methods 6: 135-138.
36. Dinter A, Berger EG, (1998) Golgi-disturbing agents. Histochem Cell Biol 109: 571-590.
37. Storrie B, Yang W, (1998) Dynamics of the interphase mammalian Golgi complex as revealed through drugs producing reversible Golgi disassembly. Biochim Biophys Acta 1404: 127-137.
38. Jennings BC, Nadolski MJ, Ling Y, Baker MB, Harrison ML, et al. (2009) 2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro. J Lipid Res 50: 233-242.
39. He Y, Hryciw DH, Carroll ML, Myers SA, Whitbread AK, et al. (2008) The ubiquitin-protein ligase Nedd4-2 differentially interacts with and regulates members of the Tweety family of chloride ion channels. J Biol Chem 283: 24000-24010.
40. Morimoto S, Nishimura N, Terai T, Manabe S, Yamamoto Y, et al. (2005) Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem 280: 2220-2228.
41. Sadeghi HM, Innamorati G, Dagarag M, Birnbaumer M, (1997) Palmitoylation of the V2 vasopressin receptor. Mol Pharmacol 52: 21-29.
42. Moffett S, Mouillac B, Bonin H, Bouvier M, (1993) Altered phosphorylation and desensitization patterns of a human beta 2-adrenergic receptor lacking the palmitoylated Cys341. EMBO J 12: 349-356.
43. Fukata Y, Fukata M, (2010) Protein palmitoylation in neuronal development and synaptic plasticity. Nat Rev Neurosci 11: 161-175.
44. Linder ME, Deschenes RJ, (2007) Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 8: 74-84.
45. Chavrier P, Vingron M, Sander C, Simons K, Zerial M, (1990) Molecular cloning of YPT1/SEC4-related cDNAs from an epithelial cell line. Mol Cell Biol 10: 6578-6585.
46. Wilcke M, Johannes L, Galli T, Mayau V, Goud B, et al. (2000) Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-golgi network. J Cell Biol 151: 1207-1220.
47. Dery O, Thoma MS, Wong H, Grady EF, Bunnett NW, (1999) Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor. J Biol Chem 274: 18524-18535.
48. Ohno Y, Kihara A, Sano T, Igarashi Y, (2006) Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins. Biochim Biophys Acta 1761: 474-483.
49. Fernandez-Hernando C, Fukata M, Bernatchez PN, Fukata Y, Lin MI, et al. (2006) Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase. J Cell Biol 174: 369-377.
50. Yang X, Claas C, Kraeft SK, Chen LB, Wang Z, et al. (2002) Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Mol Biol Cell 13: 767-781.
51. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, et al. (2004) Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol 167: 1231-1240.
52. Sharma C, Yang XH, Hemler ME, (2008) DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151. Mol Biol Cell 19: 3415-3425.
53. Blanpain C, Wittamer V, Vanderwinden JM, Boom A, Renneboog B, et al. (2001) Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J Biol Chem 276: 23795-23804.
54. Percherancier Y, Planchenault T, Valenzuela-Fernandez A, Virelizier JL, Arenzana-Seisdedos F, et al. (2001) Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J Biol Chem 276: 31936-31944.
55. Petaja-Repo UE, Hogue M, Leskela TT, Markkanen PM, Tuusa JT, et al. (2006) Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor. J Biol Chem 281: 15780-15789.
56. Tanaka K, Nagayama Y, Nishihara E, Namba H, Yamashita S, et al. (1998) Palmitoylation of human thyrotropin receptor: slower intracellular trafficking of the palmitoylation-defective mutant. Endocrinology 139: 803-806.
57. Hawtin SR, Tobin AB, Patel S, Wheatley M, (2001) Palmitoylation of the vasopressin V1a receptor reveals different conformational requirements for signaling, agonist-induced receptor phosphorylation, and sequestration. J Biol Chem 276: 38139-38146.
58. Zuckerman DM, Hicks SW, Charron G, Hang HC, Machamer CE, (2011) Differential regulation of two palmitoylation sites in the cytoplasmic tail of the beta1-adrenergic receptor. J Biol Chem 286: 19014-19023.
59. Ng GY, Mouillac B, George SR, Caron M, Dennis M, et al. (1994) Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur J Pharmacol 267: 7-19.
60. Ulloa-Aguirre A, Uribe A, Zarinan T, Bustos-Jaimes I, Perez-Solis MA, et al. (2007) Role of the intracellular domains of the human FSH receptor in G(alphaS) protein coupling and receptor expression. Mol Cell Endocrinol 260-262: 153-162.
61. Fukushima Y, Saitoh T, Anai M, Ogihara T, Inukai K, et al. (2001) Palmitoylation of the canine histamine H2 receptor occurs at Cys(305) and is important for cell surface targeting. Biochim Biophys Acta 1539: 181-191.
62. Zhu H, Wang H, Ascoli M, (1995) The lutropin/choriogonadotropin receptor is palmitoylated at intracellular cysteine residues. Mol Endocrinol 9: 141-150.
63. Schulein R, Liebenhoff U, Muller H, Birnbaumer M, Rosenthal W, (1996) Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. Biochem J 313 (Pt 2): 611-616.
64. Stanley P, Caillibot V, Siminovitch L, (1975) Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell. Cell 6: 121-128.
65. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289: 739-745.
66. Katragadda M, Maciejewski MW, Yeagle PL, (2004) Structural studies of the putative helix 8 in the human beta(2) adrenergic receptor: an NMR study. Biochim Biophys Acta 1663: 74-81.
67. Ahn KH, Nishiyama A, Mierke DF, Kendall DA, (2010) Hydrophobic residues in helix 8 of cannabinoid receptor 1 are critical for structural and functional properties. Biochemistry 49: 502-511.
68. Marin EP, Krishna AG, Zvyaga TA, Isele J, Siebert F, et al. (2000) The amino terminus of the fourth cytoplasmic loop of rhodopsin modulates rhodopsin-transducin interaction. J Biol Chem 275: 1930-1936.
69. Phillips WJ, Cerione RA, (1992) Rhodopsin/transducin interactions. I. Characterization of the binding of the transducin-beta gamma subunit complex to rhodopsin using fluorescence spectroscopy. J Biol Chem 267: 17032-17039.
70. Ernst OP, Meyer CK, Marin EP, Henklein P, Fu WY, et al. (2000) Mutation of the fourth cytoplasmic loop of rhodopsin affects binding of transducin and peptides derived from the carboxyl-terminal sequences of transducin alpha and gamma subunits. J Biol Chem 275: 1937-1943.
71. Sevigny LM, Zhang P, Bohm A, Lazarides K, Perides G, et al. (2011) Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proc Natl Acad Sci U S A 108: 8491-8496.
72. Reid HM, Mulvaney EP, Turner EC, Kinsella BT, (2010) Interaction of the human prostacyclin receptor with Rab11: characterization of a novel Rab11 binding domain within alpha-helix 8 that is regulated by palmitoylation. J Biol Chem 285: 18709-18726.
73. Charest PG, Bouvier M, (2003) Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation. J Biol Chem 278: 41541-41551.
74. Groarke DA, Drmota T, Bahia DS, Evans NA, Wilson S, et al. (2001) Analysis of the C-terminal tail of the rat thyrotropin-releasing hormone receptor-1 in interactions and cointernalization with beta-arrestin 1-green fluorescent protein. Mol Pharmacol 59: 375-385.
75. Ponimaskin E, Dumuis A, Gaven F, Barthet G, Heine M, et al. (2005) Palmitoylation of the 5-hydroxytryptamine4a receptor regulates receptor phosphorylation, desensitization, and beta-arrestin-mediated endocytosis. Mol Pharmacol 67: 1434-1443.
76. Kraft K, Olbrich H, Majoul I, Mack M, Proudfoot A, et al. (2001) Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization. J Biol Chem 276: 34408-34418.
77. Gehret AU, Jones BW, Tran PN, Cook LB, Greuber EK, et al. (2010) Role of helix 8 of the thyrotropin-releasing hormone receptor in phosphorylation by G protein-coupled receptor kinase. Mol Pharmacol 77: 288-297.
78. Lin DT, Makino Y, Sharma K, Hayashi T, Neve R, et al. (2009) Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation. Nat Neurosci 12: 879-887.